Patents by Inventor Richard Louis Price

Richard Louis Price has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF AUTISM SPECTRUM DISORDER AND ASSOCIATED SYMPTOMS
    Publication number: 20230381307
    Abstract: Disclosed is a single unit oral dosage form having, in combination, inositol and an extended release clonidine or extended release guanfacine. In one aspect, a method for treating ADHD and/or associated symptoms thereof includes administering to an ADHD patient the single unit oral dosage form. In another aspect, a method for treating ADHD and/or associated symptoms thereof includes administering to an ADHD patient inositol in combination with extended release clonidine or extended release guanfacine, whether administered separately or as a single dosage form.
    Type: Application
    Filed: August 1, 2023
    Publication date: November 30, 2023
    Inventor: Richard Louis Price
  • Treatment of autism spectrum disorder and associated symptoms
    Patent number: 11744891
    Abstract: Disclosed is a single unit oral dosage form having, in combination, inositol and an extended release clonidine or extended release guanfacine. In one aspect, a method for treating ADHD and/or associated symptoms thereof includes administering to an ADHD patient the single unit oral dosage form. In another aspect, a method for treating ADHD and/or associated symptoms thereof includes administering to an ADHD patient inositol in combination with extended release clonidine or extended release guanfacine, whether administered separately or as a single dosage form.
    Type: Grant
    Filed: May 12, 2020
    Date of Patent: September 5, 2023
    Inventor: Richard Louis Price
  • TREATMENT OF AUTISM SPECTRUM DISORDER AND ASSOCIATED SYMPTOMS
    Publication number: 20200268882
    Abstract: Disclosed is a single unit oral dosage form having, in combination, inositol and an extended release clonidine or extended release guanfacine. In one aspect, a method for treating ADHD and/or associated symptoms thereof includes administering to an ADHD patient the single unit oral dosage form. In another aspect, a method for treating ADHD and/or associated symptoms thereof includes administering to an ADHD patient inositol in combination with extended release clonidine or extended release guanfacine, whether administered separately or as a single dosage form.
    Type: Application
    Filed: May 12, 2020
    Publication date: August 27, 2020
    Inventor: Richard Louis Price
  • Treatment of autism spectrum disorder and associated symptoms
    Patent number: 10688179
    Abstract: Disclosed is a single unit oral dosage form having, in combination, inositol and an extended release clonidine or extended release guanfacine. In one aspect, a method for treating ADHD and/or associated symptoms thereof includes administering to an ADHD patient the single unit oral dosage form. In another aspect, a method for treating ADHD and/or associated symptoms thereof includes administering to an ADHD patient inositol in combination with extended release clonidine or extended release guanfacine, whether administered separately or as a single dosage form.
    Type: Grant
    Filed: August 1, 2019
    Date of Patent: June 23, 2020
    Inventor: Richard Louis Price
  • TREATMENT OF AUTISM SPECTRUM DISORDER AND ASSOCIATED SYMPTOMS
    Publication number: 20190351054
    Abstract: Disclosed is a single unit oral dosage form having, in combination, inositol and an extended release clonidine or extended release guanfacine. In one aspect, a method for treating ADHD and/or associated symptoms thereof includes administering to an ADHD patient the single unit oral dosage form. In another aspect, a method for treating ADHD and/or associated symptoms thereof includes administering to an ADHD patient inositol in combination with extended release clonidine or extended release guanfacine, whether administered separately or as a single dosage form.
    Type: Application
    Filed: August 1, 2019
    Publication date: November 21, 2019
    Inventor: Richard Louis Price
  • INOSITOL-CONTAINING COMESTIBLE UNITS AND METHODS OF TREATMENT USING THE SAME
    Publication number: 20190015354
    Abstract: A method for treating a patient having a psychiatric disorder and/or certain psychological or neurological symptoms is disclosed. The method includes administering to the patient one or more comestible units, e.g., cookies, cumulatively comprising a therapeutically effective amount of inositol, optionally at least 12,000 mg inositol.
    Type: Application
    Filed: September 17, 2018
    Publication date: January 17, 2019
    Inventor: Richard Louis Price
  • Inositol-containing comestible units and methods of treatment using the same
    Patent number: 10098848
    Abstract: A method for treating a patient having one or more of anxiety, hypersensitivity, restricted areas of interest, repetitive behaviors, irritability and emotional lability, or otherwise requiring a calming effect, is disclosed. The method includes administering to the patient a plurality of comestible units, e.g., cookies, cumulatively comprising a therapeutically effective amount of inositol.
    Type: Grant
    Filed: November 8, 2016
    Date of Patent: October 16, 2018
    Inventor: Richard Louis Price
  • TREATMENT OF ATTENTION DEFICIT DISORDERS AND ASSOCIATED SYMPTOMS
    Publication number: 20170348417
    Abstract: Disclosed is a single unit oral dosage form having, in combination, inositol and an extended release clonidine or extended release guanfacine. In one aspect, a method for treating ADHD and/or associated symptoms thereof includes administering to an ADHD patient the single unit oral dosage form. In another aspect, a method for treating ADHD and/or associated symptoms thereof includes administering to an ADHD patient inositol in combination with extended release clonidine or extended release guanfacine, whether administered separately or as a single dosage form.
    Type: Application
    Filed: August 22, 2017
    Publication date: December 7, 2017
    Inventor: Richard Louis Price
  • TREATMENT OF AUTISTIC SPECTRUM DISORDER
    Publication number: 20170151216
    Abstract: A kit, optionally for treating a patient having ASD, is disclosed. The kit includes at least one first package and at least one second package. The first package contains an alpha-2 adrenergic agonist in an extended release dosage form. The second package contains inositol.
    Type: Application
    Filed: February 10, 2017
    Publication date: June 1, 2017
    Inventor: Richard Louis Price
  • Treatment of autistic spectrum disorder
    Patent number: 9603812
    Abstract: A method for treating a patient having ASD is disclosed. The method includes administering to the patient a therapeutically effective amount of an alpha-2 adrenergic agonist in an extended release dosage form in combination with a therapeutically effective amount of inositol.
    Type: Grant
    Filed: April 4, 2014
    Date of Patent: March 28, 2017
    Inventor: Richard Louis Price
  • INOSITOL-CONTAINING COMESTIBLE UNITS AND METHODS OF TREATMENT USING THE SAME
    Publication number: 20170049715
    Abstract: A method for treating a patient having one or more of anxiety, hypersensitivity, restricted areas of interest, repetitive behaviors, irritability and emotional lability, or otherwise requiring a calming effect, is disclosed. The method includes administering to the patient a plurality of comestible units, e.g., cookies, cumulatively comprising a therapeutically effective amount of inositol.
    Type: Application
    Filed: November 8, 2016
    Publication date: February 23, 2017
    Inventor: Richard Louis Price
  • Diagnosis and treatment of P.R.I.C.E. syndrome
    Patent number: 9211284
    Abstract: A method for treating a patient having P.R.I.C.E. Syndrome is disclosed. The method includes administering to the patient a therapeutically effective amount of an alpha-2 adrenergic agonist in an extended release dosage form.
    Type: Grant
    Filed: April 11, 2013
    Date of Patent: December 15, 2015
    Inventor: Richard Louis Price
  • INOSITOL-CONTAINING COMESTIBLE UNITS AND METHODS OF TREATING AUTISTIC SPECTRUM DISORDER USING THE SAME
    Publication number: 20150126572
    Abstract: A method for treating a patient having ASD is disclosed. The method includes administering to the patient a plurality of comestible units, e.g., cookies, cumulatively comprising a therapeutically effective amount of inositol. The method may further include administering to the patient a therapeutically effective amount of an alpha-2 adrenergic agonist in an extended release dosage form.
    Type: Application
    Filed: January 14, 2015
    Publication date: May 7, 2015
    Inventor: Richard Louis Price
  • DIAGNOSIS AND TREATMENT OF P.R.I.C.E. SYNDROME
    Publication number: 20140309269
    Abstract: A method for treating a patient having P.R.I.C.E. Syndrome is disclosed. The method includes administering to the patient a therapeutically effective amount of an alpha-2 adrenergic agonist in an extended release dosage form.
    Type: Application
    Filed: April 11, 2013
    Publication date: October 16, 2014
    Inventor: Richard Louis Price
  • TREATMENT OF AUTISTIC SPECTRUM DISORDER
    Publication number: 20140309271
    Abstract: A method for treating a patient having ASD is disclosed. The method includes administering to the patient a therapeutically effective amount of an alpha-2 adrenergic agonist in an extended release dosage form in combination with a therapeutically effective amount of inositol.
    Type: Application
    Filed: April 4, 2014
    Publication date: October 16, 2014
    Inventor: Richard Louis Price
  • DIAGNOSIS AND TREATMENT OF A FORM OF AUTISTIC SPECTRUM DISORDER
    Publication number: 20140309270
    Abstract: A method for treating a patient having P.R.I.C.E. Syndrome is disclosed. The method includes administering to the patient a therapeutically effective amount of an alpha-2 adrenergic agonist in an extended release dosage form, optionally in combination with a therapeutically effective amount of inositol and/or NAC.
    Type: Application
    Filed: January 28, 2014
    Publication date: October 16, 2014
    Inventor: Richard Louis Price